首页 正文

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma

{{output}}
A key hallmark of cancer, altered metabolism, is central to cancer pathogenesis and therapy resistance. Robust glutamine metabolism is among cellular processes regulating tumor progression and responsiveness to therapy in a number of cancers, including melanom... ...